98 related articles for article (PubMed ID: 24990506)
1. Synthesis and structure-activity relationship study of triazine-based inhibitors of the DNA binding of NF-κB.
Fujii S; Kobayashi T; Nakatsu A; Miyazawa H; Kagechika H
Chem Pharm Bull (Tokyo); 2014; 62(7):700-8. PubMed ID: 24990506
[TBL] [Abstract][Full Text] [Related]
2. A new small molecule that directly inhibits the DNA binding of NF-kappaB.
Kobayashi T; Yoshimori A; Kino K; Komori R; Miyazawa H; Tanuma SI
Bioorg Med Chem; 2009 Jul; 17(14):5293-7. PubMed ID: 19539480
[TBL] [Abstract][Full Text] [Related]
3. Evans Blue is an inhibitor of nuclear factor-kappa B (NF-kappaB)-DNA binding.
Sharma RK; Otsuka M; Pande V; Inoue J; João Ramos M
Bioorg Med Chem Lett; 2004 Dec; 14(24):6123-7. PubMed ID: 15546742
[TBL] [Abstract][Full Text] [Related]
4. Biological evaluation, chelation, and molecular modeling studies of novel metal-chelating inhibitors of NF-kappaB-DNA binding: structure activity relationships.
Sharma RK; Chopra S; Sharma SD; Pande V; Ramos MJ; Meguro K; Inoue J; Otsuka M
J Med Chem; 2006 Jun; 49(12):3595-601. PubMed ID: 16759101
[TBL] [Abstract][Full Text] [Related]
5. Fluorescent thermal shift-based method for detection of NF-κB binding to double-stranded DNA.
Leitner PD; Vietor I; Huber LA; Valovka T
Sci Rep; 2021 Jan; 11(1):2331. PubMed ID: 33504856
[TBL] [Abstract][Full Text] [Related]
6. Inverse regulation of the nuclear factor-kappaB binding to the p53 and interleukin-8 kappaB response elements in lesional psoriatic skin.
Johansen C; Flindt E; Kragballe K; Henningsen J; Westergaard M; Kristiansen K; Iversen L
J Invest Dermatol; 2005 Jun; 124(6):1284-92. PubMed ID: 15955105
[TBL] [Abstract][Full Text] [Related]
7. Thiopental inhibits tumor necrosis factor alpha-induced activation of nuclear factor kappaB through suppression of kappaB kinase activity.
Loop T; Humar M; Pischke S; Hoetzel A; Schmidt R; Pahl HL; Geiger KK; Pannen BH
Anesthesiology; 2003 Aug; 99(2):360-7. PubMed ID: 12883408
[TBL] [Abstract][Full Text] [Related]
8. Novel mechanism of inhibition of nuclear factor-kappa B DNA-binding activity by diterpenoids isolated from Isodon rubescens.
Leung CH; Grill SP; Lam W; Han QB; Sun HD; Cheng YC
Mol Pharmacol; 2005 Aug; 68(2):286-97. PubMed ID: 15872117
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological evaluation of benzofuran- and 2,3-dihydrobenzofuran-2-carboxylic acid N-(substituted)phenylamide derivatives as anticancer agents and inhibitors of NF-κB.
Choi M; Jo H; Park HJ; Sateesh Kumar A; Lee J; Yun J; Kim Y; Han SB; Jung JK; Cho J; Lee K; Kwak JH; Lee H
Bioorg Med Chem Lett; 2015 Jun; 25(12):2545-9. PubMed ID: 25953156
[TBL] [Abstract][Full Text] [Related]
10. Eriocalyxin B inhibits nuclear factor-kappaB activation by interfering with the binding of both p65 and p50 to the response element in a noncompetitive manner.
Leung CH; Grill SP; Lam W; Gao W; Sun HD; Cheng YC
Mol Pharmacol; 2006 Dec; 70(6):1946-55. PubMed ID: 16940413
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of nuclear factor kappaB proteins-platinated DNA interactions correlates with cytotoxic effectiveness of the platinum complexes.
Brabec V; Kasparkova J; Kostrhunova H; Farrell NP
Sci Rep; 2016 Aug; 6():28474. PubMed ID: 27574114
[TBL] [Abstract][Full Text] [Related]
12. Electrophoretic mobility shift assay analysis of NF-κB DNA binding.
Ramaswami S; Hayden MS
Methods Mol Biol; 2015; 1280():3-13. PubMed ID: 25736740
[TBL] [Abstract][Full Text] [Related]
13. The nuclear I kappaB protein I kappaB zeta specifically binds NF-kappaB p50 homodimers and forms a ternary complex on kappaB DNA.
Trinh DV; Zhu N; Farhang G; Kim BJ; Huxford T
J Mol Biol; 2008 May; 379(1):122-35. PubMed ID: 18436238
[TBL] [Abstract][Full Text] [Related]
14. Neuroadaptations in human chronic alcoholics: dysregulation of the NF-kappaB system.
Okvist A; Johansson S; Kuzmin A; Bazov I; Merino-Martinez R; Ponomarev I; Mayfield RD; Harris RA; Sheedy D; Garrick T; Harper C; Hurd YL; Terenius L; Ekström TJ; Bakalkin G; Yakovleva T
PLoS One; 2007 Sep; 2(9):e930. PubMed ID: 17895971
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of 2,3-dihydro- and 5-chloro-2,3-dihydro-naphtho-[1,2-b]furan-2-carboxylic acid N-(substitutedphenyl)amide analogs and their biological activities as inhibitors of NF-κB activity and anticancer agents.
Choi M; Jo H; Kim D; Yun J; Kang JS; Kim Y; Jung JK; Hong JT; Cho J; Kwak JH; Lee H
Arch Pharm Res; 2016 May; 39(5):618-30. PubMed ID: 27021311
[TBL] [Abstract][Full Text] [Related]
16. Ligand binding studies, preliminary structure-activity relationship and detailed mechanistic characterization of 1-phenyl-6,6-dimethyl-1,3,5-triazine-2,4-diamine derivatives as inhibitors of Escherichia coli dihydrofolate reductase.
Srinivasan B; Tonddast-Navaei S; Skolnick J
Eur J Med Chem; 2015 Oct; 103():600-14. PubMed ID: 26414808
[TBL] [Abstract][Full Text] [Related]
17. Development of a novel furocoumarin derivative inhibiting NF-κB dependent biological functions: design, synthesis and biological effects.
Borgatti M; Chilin A; Piccagli L; Lampronti I; Bianchi N; Mancini I; Marzaro G; dall'Acqua F; Guiotto A; Gambari R
Eur J Med Chem; 2011 Oct; 46(10):4870-7. PubMed ID: 21864947
[TBL] [Abstract][Full Text] [Related]
18. Fluorescence resonance energy transfer-based method for detection of DNA binding activities of nuclear factor kappaB.
He HJ; Pires R; Zhu TN; Zhou A; Gaigalas AK; Zou S; Wang L
Biotechniques; 2007 Jul; 43(1):93-8. PubMed ID: 17695258
[TBL] [Abstract][Full Text] [Related]
19. Dimeric procyanidins are inhibitors of NF-kappaB-DNA binding.
Mackenzie GG; Delfino JM; Keen CL; Fraga CG; Oteiza PI
Biochem Pharmacol; 2009 Nov; 78(9):1252-62. PubMed ID: 19591805
[TBL] [Abstract][Full Text] [Related]
20. Suppressive effect of novel aromatic diamine compound on nuclear factor-kappaB-dependent expression of inducible nitric oxide synthase in macrophages.
Shin HM; Byung Hak Kim ; Eun Yong Chung ; Jung SH; Yeong Shik Kim ; Kyung Rak Min ; Kim Y
Eur J Pharmacol; 2005 Oct; 521(1-3):1-8. PubMed ID: 16183054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
